Nephro Flashcards
Acute Kidney Injury - Definition & Presentation
An acute decline in kidney function, ranging from mild kidney injury to severe kidney failure, resulting in serum creatinine to rise and/or a fall in urine output
Presentations:
- Hypotension
- Kidney Insults
- Reduced urine production
Other presentations:
-dizziness & orthostatic symptoms (happening when you sit up or lie down
- hypertension
- Altered mental status
-Pericardial/pleural rub (heard on auscultation)
Acute Kidney Injury - Aetiology & Risk Factors
Can be classed into Pre-kidney, intrinsic & post-kidney causes
Pre-kidney (80% of cases):
- reduced kidney perfusion is most common:
>Hypovolaemia
>Haemorrhage
>Sepsis
>Heart failure
- Hepatorenal syndrome
Intrinsic:
- Acute Tubular Necrosis (ATN) –> Causes 45% of cases
- Interstitial nephritis
- Rapidly progressive glomerulonephritis
Post-kidney:
- Mechanical obstruction of the urinary tract
>More common in men die to prostate hyperplasia
>Tumour
>Retroperitoneal fibrosis
>strictures
Risk Factors:
- Advanced age
- Underlying kidney disease
- Sepsis
- Exposure to nephrotoxins
- Excessive fluid loss/haemorrhage
- Surgery/ Recent vascular intervention
Acute Kidney Injury - Epidemiology
AKI is seen in 10-20% of patients admitted to hospital as emergencies
Acute Kidney Injury - Differentials
1) CKD –> reduced kidney function w/ elevated creatinine = chronic, although there may be acute on chronic kidney disease
2) Increased muscle mass –> Would cause an elevation of serum creatinine, but is minor and typically non-acute
3) Drug side effect –> certain medications (i.e. cimetidine/trimethoprim) can lead to elevated serum creatinine
Acute Kidney Injury - Investigations
1st line:
- Basic metabolic profile (including urea & creatinine and Liver function tests)
- Serum potassium
- FBC
- Bicarbonate
- CRP
- Blood culture –> Sepsis is a common cause of AKI
- Urinalysis
- Urine culture
- Urine output monitoring
- Fluid challenge –> Good response supports diagnosis of pre-kidney AKI
- VBG
- CXR
- ECG –> Assess for hyperkalaemia as it is a common complication
Acute Kidney Injury - Management
Hypovolaemia:
First line:
> Fluid Resuscitation
–> Give a 500 mL bolus of intravenous fluid over 15 minutes.
Use a wide bore cannula to allow adequate fluid resuscitation.
–> Use normal saline (0.9% sodium chloride) instead if hyperkalaemia is present (potassium >5.5 mmol/L) or suspected (e.g., rhabdomyolysis)
–> Reassess haemodynamic status after the initial fluid bolus and consider whether further 250 to 500 mL boluses are required
–> If no improvement is seen after two fluid challenges, escalate the patient for senior review
> Treat underlying cause of AKI
> Review medications and stop nephrotoxins (i.e. NSAIDs & iodine contrast agents)
Hypervolaemia:
–> Can happen due to overaggressive fluid resuscitation or Oliguria (low urine output) due to intrinsic/post-kidney AKI
First line:
> Loop diuretic (supervised by a specialist)
–> furosemide: consult specialist for guidance on dose
> Treat underlying cause
consider:
- Renal replacement therapy
Acute Kidney Injury - Prognosis & Complications
Recovery depends on cause of injury and the severity & duration of AKI
Predictors of poor prognosis:
-needing dialysis –> Mortality exceeds 50%
-Multi-organ failure
5 year survival rate from 15-35%
Complications:
- Hyperphosphatemia = high chance
- Hyperkalaemia = high chance
- Uraemia = medium chance
- Chronic progressive kidney disease = medium chance -> kidneys permanently damaged and do not return to baseline
- End-stage kidney disease = medium chance -> Some cannot recover, possibly due to comorbidities, and renal replacement therapy may be required
Bladder Cancer - Definition & Presentation
Over 90% of cancers of the urinary bladder are urothelial carcinoma
Non-muscle-invasive tumours are most common
Low-grade tumours are papillary and generally easy to visualise, but often have negative cytology
High-grade tumours are often flat or in situ and difficult to visualise, but typically have a positive cytology
Presentations:
- Haematuria
- Dysuria (painful urination)
(Common Cancer Symptoms)
- Unexplained weight loss
- Fatigue
- Pain
- Night sweats
Bladder Cancer - Aetiology & Risk Factors
Smoking is the most important causative factor in bladder cancer, with an attributable risk of around 50%
Risk Factors:
- Smoking
- Occupational exposure to chemical carcinogens
- painters, hairdressers, and medical and clerical personnel
- T2DM
- Increasing age
- Chronic irritation/inflammation (e.g., chronic urinary tract infection, Schistosoma infection, chronic indwelling catheters)
–> can lead to Keratinising squamous metaplasia
–> which can lead to squamous cell carcinoma of the bladder
Bladder Cancer - Epidemiology
Bladder cancer is among the top 10 most common cancer types in the world
It is the sixth most common cancer in men and the 17th most common cancer in women
Overall, non-Hispanic white people have the highest incidence rate; however, black people have a much lower survival rate than other racial groups
Bladder Cancer - Differentials
1) Benign Prostatic Hyperplasia (BPH)
-> Can cause haematuria and occurs in the same age and sex group as bladder cancer
-> BPH is associated with reduced force of stream, frequency, urgency, and nocturia, as well as enlargement of the prostate on digital rectal examination
2) Haemorrhagic cystitis
-> Acute onset of severe frequency and dysuria in a young woman, particularly if associated with low back pain and malaise, suggests haemorrhagic cystitis
-> Difficult to distinguish from bladder cancer by clinical features alone
3) Prostatitis
-> Typically occurs in men <55 years old
-> Cytology is key to the differentiating prostatitis and carcinoma of the bladder or prostate
4) UTI
-> Symptoms of urgency, frequency, dysuria, and haematuria are shared by both UTI and bladder cancer and do not aid clinical differentiation
-> Back pain, fever, and chills are common with UTI, but rare with bladder cancer
-> Positive urine culture makes bladder cancer the less likely, but does not exclude the diagnosis
5) Nephrolithiasis
-> Common cause of gross and microscopic haematuria
-> Can be distinguished by typical symptoms of renal colic
-> Look for stones w/ Non-contrast CT
Bladder Cancer - Investigations
1st order:
1) Urinalysis
–> About 80% of patients present with gross or microscopic haematuria
–> pyuria may also be seen, resulting in confusion with urinary infection
Consider:
1) Urine Cytology –> positive in up to 90% of patients with carcinoma in situ or high-grade tumours
2) Cystoscopy –> To visualise bladder tumours (is it low or high grade)
3) Renal & Bladder Ultrasounds
4) CT/MR urogram –> to inspect upper urinary tract
If Muscle invasive, do:
- CXR
- CT/MRI abdo and pelvis
- FBC
- Bone scan
Bladder Cancer - Management
Non-muscle-invasive tumours:
1) Transurethral resection of bladder tumour
2) Immediate post-op intravesical chemo
3) + intravesical BCG therapy (if intermediate/high risk)
Locally invasive tumours:
For T2a/b & T3a/b
1) Radical/partial cystectomy w/ pelvic lymph node dissection
-> possible pre/post-op chemo
2) Immunotherapy
For T4a/b
1) Chemo
-> possibly radiotherapy
-> possibly radical cystoprostatectomy
2) Immunotherapy
Metastatic disease:
1) Chemo
-> Possible Surgery or Radiotherapy
2) Immunotherapy
Bladder Cancer - Prognosis
Most patients present with low-grade, non-muscle-invasive bladder cancer (NMIBC). These patients are at high risk for tumour recurrence but low risk for disease progression and death
–> 15-year recurrence risk of 65%, but progression occurs in <5% of patients
–> Treatment with intravesical chemotherapy reduces the 2-year risk of recurrence by up to 20%
Intermediate-risk bladder cancer, without treatment, has the risk of recurrence by 15 years approaches 90%. Intravesical chemotherapy reduces recurrence by up to 20% in the short term, but has little effect on long-term recurrence
High-grade NMIBC is a risk for both recurrence and progression
Once muscle invasion occurs, overall survival is in the range of 50% even with cystectomy
Bladder Cancer - Complications
1) Prostatic urothelial carcinoma
-> by 15 years 1/4 of patients develop this when BCG maintenance is not given
2) Upper tract urothelial carcinoma
-> 1/4 of high-risk patients will develop upper tract urothelial carcinoma by 15 years and mortality is high (>30%)
-> Upper-tract carcinoma, dangerous in high-risk patients
3) Hydronephrosis
-> Tumour of the trigone, ureteral orifice, or ureter can obstruct and cause renal damage
4) Urinary retention
-> Tumours at the bladder neck can cause outlet obstruction
-> Bleeding from the tumour or post tumour resection can cause clot retention